The expression of lncRNA MEG3 in plasma was found to be negatively correlated with the NMSS score and, by comparing the expression level of MEG3 in PD and HCs, it was found that the expression of lncRNA MEG3 was significantly lower, while the NMSS score of PD patients was higher than that of the normal group. This evidence concerns the gene MEG3 and Parkinson disease.